Is BioMarin Still An Outperform At This Research Firm? By: Benzinga via Benzinga May 01, 2015 at 11:05 AM EDT In a report published Friday, Cowen and Company analysts maintained an Outperform rating on BioMarin Pharmaceutical Inc. (NASDAQ: ... Read More >> Related Stocks: Biomarin Pharmaceuticals